AMR Centre Medivir deal targets ‘superbug’ time-bomb

Microbiotix and The AMR Centre Announce Co-Development Agreement Targeting Drug Resistant P. aeruginosa in Critically Ill Pneumonia Patients...

Microbiotix and AMR Centre Announce Co-Development Agreement

Microbiotix and The AMR Centre Announce Co-Development Agreement Targeting Drug Resistant P. aeruginosa in Critically Ill Pneumonia Patients...

AMR Centre moving to new laboratories in October

The AMR Centre has signed an agreement with Alderley Park to take on some new laboratories, which will be available from early...

Dr. Pete Jackson on The AMR Centre and the O’Neill Review

The AMR Centre’s Executive Chairman, Dr. Pete Jackson, explains what The AMR Centre is doing to combat AMR, and the O’Neill...

Dr Peter Jackson addresses the ON Helix conference

More work is required to try and combat the spread of diseases that are resistant to antibiotics. That was the message from Dr Peter...

AMR Centre attends Innovation Week

The AMR Centre is delighted to have played a part during the recent Innovation Week, organised by the UK Embassy in Athens and held at the...

Call To Action

The AMR Centre is pleased to support a Call to Action to the G20 to commit investment in research, innovation and development of innovative...

CARB-X injects up to $48 million

CARB-X injects up to $48 million to accelerate first Powered by CARB-X portfolio of drug discovery and development projects to tackle...

Centre for Antimicrobial Pharmacodynamics

Professor William Hope of Liverpool University, a member of The AMR Centre’s Scientific Advisory Board, has launched a new centre to...

Powered by CARB-X

CARB-X, a global public-private partnership leading the fight against antibiotic resistance, is holding a historic event where it will...